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To the Editor: Chikungunya 
virus, an arbovirus belonging to the 
family Togaviridae, genus Alphavirus, 
was ﬁ  rst isolated in Tanzania in 1953 
(1). The ﬁ   rst outbreak in Asia was 
documented in Bangkok, Thailand, 
in 1958. Since then, outbreaks have 
been reported in Cambodia, Vietnam, 
Laos, Myanmar, Malaysia, the Philip-
pines, and Indonesia (2). In Indonesia, 
a 1972 serosurvey suggested wide-
spread distribution of chikungunya in-
fection, and numerous outbreaks have 
reemerged since 2001 (3). Malaysia 
reported its ﬁ  rst outbreak between De-
cember1998 and February 1999 and a 
reemergence in an isolated northwest-
ern coastal town in 2006 (4). 
In Singapore, although dengue fe-
ver has been endemic since the 1960s, 
the  ﬁ   rst chikungunya case was not 
reported until 2006. In 2007, 10 im-
ported cases were reported to Singa-
pore’s Ministry of Health (5). Notably, 
Taiwan reported a case involving a 
returning student from Singapore in 
November 2006, suggesting the pos-
sibility of autochthonous transmission 
in Singapore (6).
Located in tropical Southeast 
Asia, Singapore has remained vigilant 
in the surveillance of chikungunya. A 
2002/2003 serosurvey on 531 healthy 
young adults showed only 2 (0.3%) 
persons with chikungunya antibodies 
(7). We describe an outbreak of au-
tochthonous chikungunya transmis-
sion in Singapore and discuss removal 
of infectious human reservoirs from 
transmission areas as an outbreak con-
trol strategy. 
On January 14, 2008, a local case 
of chikungunya infection was detect-
ed through the general practitioners’ 
laboratory-based surveillance system 
established by Singapore’s Environ-
mental Health Institute in 2006. The 
Ministry of Health responded with a 
massive active surveillance exercise. 
A total of 2,626 people who resided 
or worked within a 150-m radius of 
the index case-patient’s address were 
screened for chikungunya infection by 
reverse transcription–PCR (RT-PCR), 
using primers adapted from Hasebe et 
al. (5,8). Persons with an acute febrile 
illness, signs or symptoms compatible 
with chikungunya fever (fever, joint 
pain, or rash), or those with positive 
RT-PCR results were referred to the 
Communicable Disease Centre at Tan 
Tock Seng Hospital (CDC/TTSH), 
the national infectious disease referral 
center in Singapore.
During the outbreak period from 
January 14 to February 21, 2008, chi-
kungunya infection was conﬁ  rmed for 
13 patients (5). Of these, 10 acutely 
symptomatic patients (all men; me-
dian age 35 years, range 22–69 years) 
were isolated at CDC/TTSH until fe-
ver resolved and a negative chikungu-
nya RT-PCR test result was obtained. 
During hospitalization, patients’ tem-
peratures were monitored every 4 
hours and daily chikungunya RT-PCR 
tests were performed. Viral load pro-
ﬁ   les were derived from an external 
standard curve generated by 10-fold 
serially diluted virus from a concen-
tration of 108 pfu/mL, using crossing-
point values.
 The Table summarizes the pres-
ence of viremia and patients’ febrile 
status in relation to the day of illness. 
High levels of viremia were observed 
during the ﬁ  rst 5 days of illness (me-
dian 119,126 pfu/mL, range 360–
14,605,314 pfu/mL). Fever lasted a 
median of 5 days (range 3–10 days); 
viremia persisted up to day 9 of ill-
ness. Our ﬁ  ndings concur with those 
of a European study, suggesting ex-
tremely high levels of viremia at the 
initial stage of chikungunya disease 
(9). Notably, 1 patient (patient 4), 
who was screened by the Ministry of 
Health, was observed to have a posi-
tive chikungunya RT-PCR test result 
1 day before symptom onset. Fever 
resolution did not predict viral clear-
ance. Of note, 30% of our patients had 
detectable viremia (376–8,523 pfu/
mL), after fever had resolved. We are 
uncertain of the role of level of viremia 
in the transmission of chikungunya; 
more research is needed to address 
this pertinent public health question. 
Aedes aegypti mosquitoes were 
the vectors involved in this outbreak. 
Viral sequences from our patients 
showed a close association to the circu-
lating strains in the 2006 Indian Ocean 
outbreak (GenBank accession nos. 
EU441882 and EU441883), without 
the E1-A226V mutation, which can 
increase transmission of the virus in 
the alternate vector Ae. albopictus (5). 
Virus phylogenetic studies supported 
the notion that the East African geno-
type, which emerged in Kenya in 2004 
and the Indian Ocean islands in 2005, 
closely resembling the 2006 outbreak 
strain in India, arrived in Singapore in 
January 2008. 
Singapore’s outbreak containment 
strategy focused primarily on inten-
sive vector control and rapid removal 
of infectious human reservoirs through 
active case ﬁ  nding and isolation. The 
proportion of asymptomatic infections 
in this outbreak was not determined. 
Asymptomatic infections could possi-
bly reduce the effectiveness of control 
efforts. However, there have been no 
data thus far supporting chikungunya 
transmissibility in asymptomatic per-
sons. Detectable viremia before clinical 
signs and symptoms and high levels of 
viremia during early illness, as demon-
strated in our study and others (9,10), 
pose logistical challenges in the timeli-
ness of case detection for isolation. 
Singapore remains at risk for chi-
kungunya outbreaks. It has a highly 
susceptible population, a porous bor-
der with large travel volumes from 
epidemic areas, and effective vectors 
(both Ae. aegypti and Ae. albopictus). 
In the absence of a vaccine, high vigi-
lance for autochthonous transmission 
and stringent vector control should be 
maintained along with a swift public 
health response.   
836  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 5, May 2009LETTERS
Yee S. Leo, Angela L.P. Chow,  
Li Kiang Tan, David C. Lye, 
Li Lin, and Lee C. Ng
Author afﬁ  liations: Tan Tock Seng Hospital, 
Singapore (Y.S. Leo, A.L.P. Chow, D.C. Lye, 
L. Lin); and National Environment Agency, 
Singapore (L.K. Tan, L.C. Ng)
DOI: 10.3201/eid1505.081390
References
  1.   Robinson MC. An epidemic of virus dis-
ease in Southern Province, Tanganyika 
Territory, in 1952–53. I. Clinical features. 
Trans R Soc Trop Med Hyg. 1955;49:28–
32. DOI: 10.1016/0035-9203(55)90080-8
    2.    Schuffenecker I, Iteman I, Michault A, 
Murri S, Frangeul L, Vaney MC, et al. Ge-
nome microevolution of chikungunya vi-
ruses causing the Indian Ocean outbreak. 
PLoS Med. 2006;3:e263. Medline DOI: 
10.1371/journal.pmed.0030263
    3.    Laras K, Sukri NC, Larasati RP, Bangs 
MJ, Kosim R, Djauzi, et al. Tracking the 
re-emergence of epidemic chikungunya 
virus in Indonesia. Trans R Soc Trop Med 
Hyg. 2005;99:128–41. DOI: 10.1016/j.
trstmh.2004.03.013
  4.   AbuBakar S, Sam IC, Wong PR. MatRa-
him NZ, Hooi PS, Roslan N. Reemer-
gence of endemic chikungunya, Malaysia. 
Emerg Infect Dis. 2007;13:147–9.
  5.   Ministry of Health, Singapore. Singapore’s 
ﬁ  rst chikungunya outbreak – surveillance 
and response. Epidemiological News Bul-
letin, 2008 [cited 2009 Mar 26]. Available 
from http://www.moh.gov.sg/mohcorp/
publicationsnewsbulletins.aspx?id=19542
    6.   Shu PY, Yang CF, Su CL, Chen CY, 
Chang SF, Tsai KH, et al. Two imported 
chikungunya cases, Taiwan. Emerg In-
fect Dis. 2008;14:1325–7. DOI: 10.3201/
eid1408.071304
  7.   Ministry of Health, Singapore. Chikungu-
nya virus disease. Epidemiological News 
Bulletin, 2006 [cited 2009 Mar 26]. Avail-
able from http://www.moh.gov.sg/mohcorp/
publicationsnewsbulletins.aspx?id=12478
  8.   Hasebe F, Parquet MC, Pandey BD, Ma-
thenge EG, Morita K, Balasubramaniam V, 
et al. Combined detection and genotyping 
of chikungunya virus by a speciﬁ  c reverse 
transcription–polymerase chain reaction. J 
Med Virol. 2002;67:370–4. DOI: 10.1002/
jmv.10085
  9.   Panning M, Grywna K, van Esbroeck M, 
Emmerich P, Drosten C. Chikungunya fe-
ver in travelers returning to Europe from 
the Indian Ocean region, 2006. Emerg In-
fect Dis. 2008;14:416–22. DOI: 10.3201/
eid1403.070906
10.   Parola P, de Lamballerie X, Jourdan J, Ro-
very C, Vaillant V, Minodier P, et al. Novel 
chikungunya virus variant in travelers re-
turning from Indian Ocean islands. Emerg 
Infect Dis. 2006;12:1493–9.
Address for correspondence: Yee Sin Leo, 
Department of Infectious Diseases, Tan Tock 
Seng Hospital, 11 Jalan Tan Tock Seng 308433, 
Singapore; yee_sin_leo@ttsh.com.sg 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 5, May 2009  837 
Table. Daily trend of fever and viremia in 10 hospitalized chikungunya patients, Singapore 
Fever† and chikungunya test results (viral load‡), by day of fever  Patient
no.
Signs and 
symptoms*  – 1 0 1 2 3 4 5678 9 1 0
1 F, A, B, D  NA
+
(442.7)
37.7§
+
(3.5)
37.0
–
37.0
–
2 F, A, H, RE  NA
+
(5,191.4) 
39.6§
+
(3,655.2) 
38.4
+
(119.1)
38.0
+
(1.3)
37.6
–
38.5 38.0 37.4
3 F, A, R, H NA
+
(155.5)
39.3§
+
(385.2)
37.0
+
(3.7)
37.2
+
(0.4)
37.3
–
37.2
–
4F , A N A
+
(0.8)
40.8§
+
(14,605.3)
39.9
+
(14,170.2)
38.2
+
(1,007.8) 
37.6
+
(4.0)
37.6
+
(0.2)
37.4
–
37.0
5F , A NA
+
(371.4)
37.0§
+
(25.9)
37.8
+
(0.4)
36.8
–
36.6
–
6 F, D, R, M  NA
+
(524.4)
37.6§
+
(0.7)
38.6
+
(0.4)
37.2
–
36.8
–
7 F, A, H, EP  NA
+
(18.8)
38.3§
+
(7.2)
37.0
+
(0.4)
37.0
–
8F , A NA
+
(36.6)
37.5§ 37.6
+
(0.3)
37.7
–
36.4
9 F, A, N  NA
+
(406.7)
38.4§
–
37.8 37.1 37.1
10 F, A, M  39.2§ 36.7
+
(8.5)
36.8
+
(3.6)
37.1
–
37.4
–
36.8
*At hospitalization. F, fever; A, arthralgia; B, backache; D, diarrhea; H, headache; RE, red eyes; R, rash; M, myalgia; EP, eye pain; N, nausea. 
†Day 0, day of fever onset. Maximum temperature expressed in ºC. Light shading indicates self-reported fever; dark shading indicates documented fever 
(maximum temperature >37.5 ºC). NA, not available. 
‡Viral load expressed as × 10
3 pfu/mL. Reverse transcription–PCR test results for chikungunya: +, positive; –, negative. 
§Indicates day patient was hospitalized. 